Best Revuforj (Revumenib) Medicine in India

Revuforj (Revumenib) is a targeted anticancer treatment used for adults and children aged 1 year and older with relapsed or refractory acute myeloid leukemia (AML) that has a susceptible KMT2A translocation, also known as a KMT2A rearrangement. It is used when the leukemia has returned after previous treatment or has not responded adequately to earlier therapies. Revumenib is designed to target the underlying molecular abnormality associated with this type of leukemia and help control the growth of abnormal blood cells.

Revuforj (Revumenib) belongs to a class of targeted treatments known as menin inhibitors. It works by blocking the interaction between the menin protein and KMT2A, which plays an important role in the development and maintenance of certain leukemia cells. By disrupting this abnormal signaling pathway, Revumenib helps reduce the expression of genes that support leukemia cell growth and survival, promoting the differentiation and elimination of abnormal leukemia cells.

Revuforj (Revumenib) should be used exactly as prescribed by your doctor and continued for as long as recommended based on your condition and treatment response. Regular blood tests and medical examinations may be required during treatment to monitor blood cell counts, liver function, and other aspects of your health. Your doctor may also monitor your heart rhythm because Revumenib can cause QT interval prolongation, which may affect the heart's electrical activity. Inform your doctor about all medical conditions and medicines, vitamins, herbal products, or supplements you are taking before starting treatment, and report any unusual or worsening symptoms promptly.

Treatment of KMT2A-Rearranged Acute Myeloid Leukemia (AML)

Revuforj (Revumenib) is used to treat adults and children aged 1 year and older with relapsed or refractory acute myeloid leukemia (AML) involving a KMT2A translocation. It works by blocking the interaction between the menin protein and the altered KMT2A protein, helping disrupt the abnormal genetic signals that support leukemia cell growth and survival. By targeting this specific molecular abnormality, Revuforj (Revumenib) can help reduce the number of abnormal leukemia cells and may help achieve remission in eligible patients whose disease has returned or has not responded to previous treatment.

Some side effects of Revuforj (Revumenib) may improve as the body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Revuforj (Revumenib)

Take Revuforj (Revumenib) exactly as prescribed by your doctor. It is usually taken twice daily, approximately 12 hours apart, and may be taken with or without food. Swallow it whole with water and do not crush, chew, or break it. Take each dose at approximately the same time every day. If you miss a dose, follow your doctor's instructions and do not take an extra dose unless advised. Continue treatment for as long as recommended by your healthcare professional.

Revuforj (Revumenib) is a targeted menin inhibitor that works by blocking the interaction between the menin protein and KMT2A. In certain types of acute myeloid leukemia (AML), KMT2A rearrangements can activate abnormal genetic programs that promote the growth and survival of leukemia cells. By disrupting the menin-KMT2A interaction, Revumenib helps turn off these abnormal signals, allowing leukemia cells to differentiate and reducing their ability to grow and survive.

• Keep Revuforj tablets at a controlled room temperature of 20°C to 25°C.
• Temperature excursions between 15°C and 30°C are permitted.
• Store the tablets in the original bottle with the supplied desiccant and keep the container properly closed.
• Keep the medicine in a secure place that is out of reach of children.

Alcohol CONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Revuforj (Revumenib).

Pregnancy CONSULT YOUR DOCTOR

Revuforj may cause serious harm to an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception during treatment as advised by your doctor.

Breastfeeding CONSULT YOUR DOCTOR

Breastfeeding is not recommended during treatment with Revuforj. Consult your doctor for guidance on when breastfeeding can be safely resumed.

Driving CONSULT YOUR DOCTOR

Revuforj may cause fatigue, dizziness, or other effects that can affect your ability to drive safely. Avoid driving if your alertness or ability to concentrate is affected.

Kidney CAUTION

Inform your doctor if you have kidney problems before starting treatment. Your doctor may recommend additional monitoring based on your kidney function.

Liver CAUTION

Tell your doctor if you have liver problems. Revuforj may affect liver function, so additional monitoring or dose adjustment may be required.

• Take Revuforj (Revumenib) exactly as prescribed by your doctor and follow the recommended dosing schedule.
• Take each dose at approximately the same time every day to maintain consistent treatment.
• Swallow it whole with water and do not crush, chew, or break it.
• Attend regular blood tests and medical check-ups as recommended by your doctor.
• Report symptoms such as fainting, dizziness, irregular heartbeat, unusual bleeding, fever, or other new or worsening symptoms promptly.
• Read More About - Revuforj (Revumenib) from Pharma Five.

Pharma Five, may assist patients in arranging the import of Revuforj (Revumenib) in small quantities for personal medical use. The applicant is required to submit an application in Form 12A along with a prescription issued by a Registered Medical Practitioner (RMP).

Pharma Five offers experienced pharmaceutical facilitation services to help patients access Revuforj (Revumenib) and other specialized pharmaceutical products through professional import assistance. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.